当前位置: X-MOL 学术Org. Process Res. Dev. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Early Development Scale-Up of a Structurally-Challenging 5-Lipoxygenase Activating Protein (FLAP) Inhibitor
Organic Process Research & Development ( IF 3.4 ) Pub Date : 2017-07-18 00:00:00 , DOI: 10.1021/acs.oprd.7b00202
Jason A. Mulder 1 , Joe Gao 1 , Keith R. Fandrick 1 , Xingzhong Zeng 1 , Jean-Nicolas Desrosiers 1 , Nitinchandra D. Patel 1 , Zhibin Li 1 , Sonia Rodriguez 1 , Jon C. Lorenz 1 , Jun Wang 1 , Shengli Ma 1 , Daniel R. Fandrick 1 , Nelu Grinberg 1 , Heewon Lee 1 , Todd Bosanac 1 , Hidenori Takahashi 1 , Zhidong Chen 1 , Alessandra Bartolozzi 1 , Peter Nemoto 1 , Carl A. Busacca 1 , Jinhua J. Song 1 , Nathan K. Yee 1 , Paige E. Mahaney 1 , Chris H. Senanayake 1
Affiliation  

A practical and efficient synthesis of the FLAP inhibitor 1 was developed addressing multiple scale-up and safety concerns posed by the established synthesis and utilized a resolution strategy (replacing supercritical fluid chromatography (SFC) separation) for expedient access to the key structural component of 1: the challenging chiral quaternary center. Also highlighted are in situ IR monitoring, condensation to form the 1,2,4-oxadiazole ring, and an efficient Suzuki-Miyaura coupling.

中文翻译:

结构具有挑战性的5-脂氧合酶激活蛋白(FLAP)抑制剂的早期发展规模。

开发了一种切实有效的FLAP抑制剂1合成方法,以解决已建立的合成方法所引起的多种放大和安全问题,并利用拆分策略(取代超临界流体色谱法(SFC)分离)方便地获得了1的关键结构成分:具有挑战性的手性四元中心。还强调了原位红外监测,缩合形成1,2,4-恶二唑环以及有效的Suzuki-Miyaura偶联。
更新日期:2017-07-19
down
wechat
bug